# Intelomed, Inc.: Form D filings

Intelomed, Inc., a biotechnology company in Pittsburgh, PA, filed 8 Form D notices with the SEC between 2010 and 2017. The latest, on January 9, 2017, reports $502,429 sold of a $1.5 million offering to 10 investors.

Find out what Intelomed, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Intelomed%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Intelomed%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fintelomed-inc-1482781)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Intelomed%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Intelomed%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fintelomed-inc-1482781)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Pennsylvania](https://specstream.ai/data/form-d/state/pennsylvania): 987 rows, by operating companies, filed since November 1, 2024, $49.35, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/pennsylvania
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: PINE CORPORATE CENTER 3, 6041 WALLACE ROAD EXT, SUITE 110, Pittsburgh, PA, 15090
- Phone: (855) 279-0551
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1482781

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jan 9, 2017 | New notice | $1,500,000 | $502,429 | $997,571 | 10 | Dec 23, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1482781/000121390017000177/0001213900-17-000177-index.htm) |
| Jan 29, 2016 | Amendment | $5,000,000 | $1,855,410 | $3,144,590 | 8 | Jan 21, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1482781/000148278116000003/0001482781-16-000003-index.htm) |
| Jan 27, 2016 | New notice | $5,000,000 | $1,855,410 | $3,144,590 | 8 | Jan 21, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1482781/000148278116000002/0001482781-16-000002-index.htm) |
| Jul 23, 2014 | New notice | $3,846,926 | $3,846,926 | $0 | 29 | Jul 15, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1482781/000148278114000002/0001482781-14-000002-index.htm) |
| Sep 10, 2013 | New notice | $2,500,000 | $2,404,582 | $95,418 | 22 | Sep 9, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1482781/000148278113000001/0001482781-13-000001-index.htm) |
| Dec 5, 2012 | New notice | $2,000,000 | $0 | $2,000,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1482781/000148278112000001/0001482781-12-000001-index.htm) |
| May 24, 2011 | New notice | $3,000,000 | $2,611,000 | $389,000 | 15 | May 13, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1482781/000148278111000001/0001482781-11-000001-index.htm) |
| Feb 1, 2010 | New notice | $500,000 | $200,000 | $300,000 | 1 | Jan 25, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1482781/000148278110000001/0001482781-10-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Jill F. Schiaparelli | Executive Officer, Director |  |
| William P. Malloy | Director |  |
| Ned Laubacher | Director |  |
| Michael Stephen Dignazio | Executive Officer |  |
| Mark P. Rossi | Director |  |
| R. Stephen Doyle | Director |  |

## Other biotechnology companies in Pennsylvania that filed recently

- [Traws Pharma, Inc.](https://specstream.ai/data/form-d/company/traws-pharma-inc-1130598) offering · Nov 5, 2026
- [BioLattice Ophthalmics, Inc,](https://specstream.ai/data/form-d/company/biolattice-ophthalmics-inc-2125596) $1.8 million · Oct 28, 2026
- [Myris Therapeutics, Inc.](https://specstream.ai/data/form-d/company/myris-therapeutics-inc-1924725) $500,000 · Oct 14, 2026
- [Praeventix, Inc.](https://specstream.ai/data/form-d/company/praeventix-inc-1952974) $5.6 million · Sep 10, 2026
- [Plowshare Therapies LLC](https://specstream.ai/data/form-d/company/plowshare-therapies-llc-2152111) $6.7 million · Aug 31, 2026
- [Noveome Biotherapeutics, Inc.](https://specstream.ai/data/form-d/company/noveome-biotherapeutics-inc-1478304) $6.8 million · Aug 27, 2026
- [AlloTRx Bio Inc.](https://specstream.ai/data/form-d/company/allotrx-bio-inc-2151424) $500,000 · Aug 24, 2026
- [Aposture Surgical Corp](https://specstream.ai/data/form-d/company/aposture-surgical-corp-2148299) $87,000 · Aug 13, 2026
- [Merlin Biotech, Inc.](https://specstream.ai/data/form-d/company/merlin-biotech-inc-2149714) $50,000 · Aug 11, 2026

[Every Form D from the week of Jan 9, 2017](https://specstream.ai/data/form-d/week/2017-01-09) · [All recent filings in Pennsylvania](https://specstream.ai/data/form-d/state/pennsylvania) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Intelomed, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).